Lauren Frayer, NPR's international correspondent, takes us inside the Serum Institute of India, the largest vaccine manufacturer in the world. She discusses their ambitious plan to produce 100 million doses per month of the Oxford-AstraZeneca vaccine, crucial for low-income countries. Frayer highlights the institute's evolution from creating anti-snake venom to a vaccine powerhouse, showcasing its agility during the COVID-19 pandemic. The conversation also touches on the complexities of vaccine patents and the importance of global partnerships in ensuring widespread access.